Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313308260> ?p ?o ?g. }
- W4313308260 endingPage "114170" @default.
- W4313308260 startingPage "114170" @default.
- W4313308260 abstract "Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition is a novel cholesterol-lowering treatment for decreasing the risk of atherosclerosis. We have previously shown that active immunization using the antiPCSK9 vaccine could decrease hypercholesterolemia and impede the development of atherosclerotic lesions in the experimental model of atherosclerosis. Here, we evaluated the toxicity of the vaccine in healthy mice.Forty male and female albino mice were divided into 4 experimental groups, including vaccine female (10 mice) and male (10 mice) groups receiving the antiPCSK9 vaccine as well as the corresponding control female (10 mice) and male (10 mice) groups receiving the phosphate buffer. Vaccination was planned based on 4 subcutaneous injections of the vaccine formulation (10 µg/mouse) in bi-weekly intervals. The toxicity study was performed by the subacute protocol, 28 days after the last vaccine injection. To this end, the plasma levels of lipid indexes, urea, creatinine, AST, ALT, ALP, and fasting plasma glucose (FPG), as well as the CBC test were measured. To evaluate histopathological alterations, various tissues including the heart, liver, kidney, spleen, and brain were studied using hematoxylin & eosin (H&E) staining by an expert pathologist. The severity of damage to the tissue was considered based on the standard classification; grade 1 as light damage, grade 2 as moderate damage, grade 3 as near intense damage, and grade 4 as intense damage.The results showed non-significant changes of total cholesterol, LDL-C, triglyceride, HDL-C, FBS, creatinine, urea, AST, ALP, ALT, and PAB in the vaccinated mice when compared with control mice. The CBS test indicated that there were no significant changes in the levels of WBC, RBC, HGB, HCT, MCH, MCHC, PLT, LYM, NEUT, MCV, RDW-S, PDW, and MPV in the vaccinated mice when compared with control mice. Evaluating histopathological alterations in various tissues indicated no significant adverse effects in vaccinated mice when compared to control mice.The findings of the present study indicate that antiPCSK9 is safe and exerts no adverse effects on the function of different organs and blood levels of cellular and biochemical biomarkers in healthy mice." @default.
- W4313308260 created "2023-01-06" @default.
- W4313308260 creator A5006330413 @default.
- W4313308260 creator A5031560022 @default.
- W4313308260 creator A5046431472 @default.
- W4313308260 creator A5088219846 @default.
- W4313308260 date "2023-02-01" @default.
- W4313308260 modified "2023-10-14" @default.
- W4313308260 title "Preclinical toxicity assessment of a peptide-based antiPCSK9 vaccine in healthy mice" @default.
- W4313308260 cites W1973830433 @default.
- W4313308260 cites W1988630960 @default.
- W4313308260 cites W2001328643 @default.
- W4313308260 cites W2027481161 @default.
- W4313308260 cites W2031638731 @default.
- W4313308260 cites W2056390664 @default.
- W4313308260 cites W2081678895 @default.
- W4313308260 cites W2123726520 @default.
- W4313308260 cites W2149383594 @default.
- W4313308260 cites W2152615674 @default.
- W4313308260 cites W2192360112 @default.
- W4313308260 cites W2201508340 @default.
- W4313308260 cites W2554832534 @default.
- W4313308260 cites W2562026504 @default.
- W4313308260 cites W2578413769 @default.
- W4313308260 cites W2596179513 @default.
- W4313308260 cites W2603623680 @default.
- W4313308260 cites W2654759377 @default.
- W4313308260 cites W2757252516 @default.
- W4313308260 cites W2781946166 @default.
- W4313308260 cites W2898502019 @default.
- W4313308260 cites W2899699851 @default.
- W4313308260 cites W2914692842 @default.
- W4313308260 cites W2946193244 @default.
- W4313308260 cites W2946529095 @default.
- W4313308260 cites W2949589992 @default.
- W4313308260 cites W2955200437 @default.
- W4313308260 cites W2955932804 @default.
- W4313308260 cites W2964503901 @default.
- W4313308260 cites W2980699729 @default.
- W4313308260 cites W2981437673 @default.
- W4313308260 cites W2981841336 @default.
- W4313308260 cites W2981861092 @default.
- W4313308260 cites W2993973239 @default.
- W4313308260 cites W2998707173 @default.
- W4313308260 cites W3000628952 @default.
- W4313308260 cites W3012265841 @default.
- W4313308260 cites W3097853954 @default.
- W4313308260 cites W3114064482 @default.
- W4313308260 cites W3134963806 @default.
- W4313308260 cites W3157368335 @default.
- W4313308260 cites W3165247221 @default.
- W4313308260 cites W3177064290 @default.
- W4313308260 cites W3196947103 @default.
- W4313308260 cites W3208552554 @default.
- W4313308260 cites W3211611719 @default.
- W4313308260 cites W4212978401 @default.
- W4313308260 cites W4238580056 @default.
- W4313308260 cites W4283370780 @default.
- W4313308260 doi "https://doi.org/10.1016/j.biopha.2022.114170" @default.
- W4313308260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36587555" @default.
- W4313308260 hasPublicationYear "2023" @default.
- W4313308260 type Work @default.
- W4313308260 citedByCount "2" @default.
- W4313308260 countsByYear W43133082602023 @default.
- W4313308260 crossrefType "journal-article" @default.
- W4313308260 hasAuthorship W4313308260A5006330413 @default.
- W4313308260 hasAuthorship W4313308260A5031560022 @default.
- W4313308260 hasAuthorship W4313308260A5046431472 @default.
- W4313308260 hasAuthorship W4313308260A5088219846 @default.
- W4313308260 hasBestOaLocation W43133082601 @default.
- W4313308260 hasConcept C125473707 @default.
- W4313308260 hasConcept C126322002 @default.
- W4313308260 hasConcept C134018914 @default.
- W4313308260 hasConcept C204232928 @default.
- W4313308260 hasConcept C2776390293 @default.
- W4313308260 hasConcept C2778163477 @default.
- W4313308260 hasConcept C2778913445 @default.
- W4313308260 hasConcept C2780306776 @default.
- W4313308260 hasConcept C29730261 @default.
- W4313308260 hasConcept C71924100 @default.
- W4313308260 hasConceptScore W4313308260C125473707 @default.
- W4313308260 hasConceptScore W4313308260C126322002 @default.
- W4313308260 hasConceptScore W4313308260C134018914 @default.
- W4313308260 hasConceptScore W4313308260C204232928 @default.
- W4313308260 hasConceptScore W4313308260C2776390293 @default.
- W4313308260 hasConceptScore W4313308260C2778163477 @default.
- W4313308260 hasConceptScore W4313308260C2778913445 @default.
- W4313308260 hasConceptScore W4313308260C2780306776 @default.
- W4313308260 hasConceptScore W4313308260C29730261 @default.
- W4313308260 hasConceptScore W4313308260C71924100 @default.
- W4313308260 hasFunder F4320322855 @default.
- W4313308260 hasLocation W43133082601 @default.
- W4313308260 hasLocation W43133082602 @default.
- W4313308260 hasOpenAccess W4313308260 @default.
- W4313308260 hasPrimaryLocation W43133082601 @default.
- W4313308260 hasRelatedWork W1969808273 @default.
- W4313308260 hasRelatedWork W1993873099 @default.
- W4313308260 hasRelatedWork W2013998010 @default.